Advertisement

Topics

Rapid Benzodiazepine Detoxification Using Flumazenil - 2

2014-08-27 04:00:15 | BioPortfolio

Summary

The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.

Study Design

Primary Purpose: Treatment

Conditions

Substance-Related Disorders

Intervention

Flumazenil

Location

Yale University, Psychiatry
New Haven
Connecticut
United States
06519

Status

Completed

Source

National Institute on Drug Abuse (NIDA)

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T04:00:15-0400

Clinical Trials [992 Associated Clinical Trials listed on BioPortfolio]

Rapid Benzodiazepine Detoxification Using Flumazenil - 1

The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.

Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm

This arm is a positron emission tomography (PET) biomechanistic GABA-A receptor target engagement study that includes detailed clinical and motor assessments before and after the i.v. admi...

Women's Treatment for Trauma and Substance Use Disorders - 1

The purpose of this study is to compare the effectiveness of adding Seeking Safety to standard substance abuse treatment to adding a control condition: Women's Health Education to standard...

Integrated Intervention for Substance Abusers With Depressive Disorders

This study is a randomized clinical trial comparing outcomes of Integrated Cognitive Behavioral Treatment plus standard medications for veterans with both substance use disorders, depressi...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

PubMed Articles [14760 Associated PubMed Articles listed on BioPortfolio]

Substance-use disorders, personality traits, and sex differences in institutionalized adolescents.

Substance-use disorder (SUD) was found to be an aggravating factor to delinquency and is closely related to personality disorders (PDs).

A review of the neurobiological underpinning of comorbid substance use and mood disorders.

There is evidence that substance use disorders and other mental disorders may have shared biological mechanisms. However, the neurobiological basis of this comorbidity remains only partially explained...

Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders.

This chapter reviews antidepressant treatment considerations and recommendations for patients with co-occurring depression and substance use disorders. Depression and substance use disorders are highl...

Change in anxiety sensitivity and substance use coping motives as putative mediators of treatment efficacy among substance users.

Anxiety sensitivity and coping motives for substance use are processes implicated in anxiety and substance use disorder (SUD) comorbidity, and are malleable treatment targets. Little is known about wh...

Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study.

Despite recognition of the negative impact of psychiatric comorbidity on addictive disorders, the mechanisms underlying this association remain poorly understood. The present investigation applied mob...

Medical and Biotech [MESH] Definitions

Disorders related to substance abuse, the side effects of a medication, toxin exposure, and ALCOHOL-RELATED DISORDERS.

A medical specialty focused on the diagnosis and treatment of ADDICTIVE BEHAVIOR disorders, including SUBSTANCE-RELATED DISORDERS and IMPULSE CONTROL DISORDERS; and the management of co-occurring medical and psychiatric conditions

These disorders are related to both SCHIZOPHRENIA SPECTRUM AND RELATED DISORDERS and DEPRESSIVE DISORDERS in terms of symptomatology, family history, and genetics. (DSM-V) .

Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.

Disorders related or resulting from abuse or mis-use of opioids.

More From BioPortfolio on "Rapid Benzodiazepine Detoxification Using Flumazenil - 2"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Searches Linking to this Trial